{"transactions":[{"id":3161378,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-05T20:23:42.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units.  Because the reporting person did not stand for election at the annual meeting on May 5, 2020, the restricted stock units vested on May 4, 2020 (the day prior to the first annual meeting of stockholders following the date of grant)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units.  Because the reporting person did not stand for election at the annual meeting on May 5, 2020, the restricted stock units vested on May 4, 2020 (the day prior to the first annual meeting of stockholders following the date of grant)."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000899243-20-012068","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/doc4.xml","form_type":"4"}},{"id":3161377,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-05T20:23:42.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":6459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":82758,"source":{"system":"sec-edgar","filing":"0000899243-20-012068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/doc4.xml","form_type":"4"}},{"id":3535237,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:46:34.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001723128-19-000067","document":"wf-form4_155735197842483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/wf-form4_155735197842483.xml","form_type":"4"}},{"id":3535236,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:46:34.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."}],"balance_after":6459,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0001723128-19-000067","document":"wf-form4_155735197842483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/wf-form4_155735197842483.xml","form_type":"4"}},{"id":3535235,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T21:46:34.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28044,"derivative":{"exercise_price":14.05,"expiration_date":"2029-05-06","underlying":"Class A Common Stock","underlying_shares":28044},"source":{"system":"sec-edgar","filing":"0001723128-19-000067","document":"wf-form4_155735197842483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/wf-form4_155735197842483.xml","form_type":"4"}},{"id":3535234,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-08T21:46:34.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":76299,"source":{"system":"sec-edgar","filing":"0001723128-19-000067","document":"wf-form4_155735197842483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/wf-form4_155735197842483.xml","form_type":"4"}},{"id":3606450,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-07T22:41:33.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2019-05-20","underlying":"Class A Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001723128-19-000038","document":"wf-form4_155199847854964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/wf-form4_155199847854964.xml","form_type":"4"}},{"id":3606449,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-07T22:41:33.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":45000,"price":6.55,"value":294750.0,"ownership":{"direct":true},"balance_after":70192,"source":{"system":"sec-edgar","filing":"0001723128-19-000038","document":"wf-form4_155199847854964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/wf-form4_155199847854964.xml","form_type":"4"}},{"id":3606448,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-07T22:41:33.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":23345,"price":12.39,"value":289244.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $12.39 per share to $12.38 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25192,"source":{"system":"sec-edgar","filing":"0001723128-19-000038","document":"wf-form4_155199847854964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/wf-form4_155199847854964.xml","form_type":"4"}},{"id":3942739,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":6107,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942738,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":24977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":24977,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":24977},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942737,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":45000,"derivative":{"exercise_price":6.55,"expiration_date":"2019-05-20","underlying":"Class A Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942736,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":10000,"derivative":{"exercise_price":20.3,"expiration_date":"2020-05-26","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942735,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":10000,"derivative":{"exercise_price":27.97,"expiration_date":"2021-05-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942734,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":10000,"derivative":{"exercise_price":20.9,"expiration_date":"2022-05-23","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942733,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":12000,"derivative":{"exercise_price":17.99,"expiration_date":"2023-05-15","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942732,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":11500,"derivative":{"exercise_price":25.24,"expiration_date":"2024-05-14","underlying":"Class A Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942731,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":7300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":7300,"derivative":{"exercise_price":44.85,"expiration_date":"2025-05-12","underlying":"Class A Common Stock","underlying_shares":7300},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942730,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":10575,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":10575,"derivative":{"exercise_price":30.33,"expiration_date":"2026-05-17","underlying":"Class A Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942729,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":10575,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":10575,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Class A Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3942728,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-05-08T23:25:16.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":48537,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 48,537 shares of Impax Laboratories, Inc. (\"Impax\") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the \"BCA\")."}],"balance_after":48537,"source":{"system":"sec-edgar","filing":"0000899243-18-011946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011946/doc4.xml","form_type":"4"}},{"id":3943131,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2019-05-20","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943130,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":20.3,"expiration_date":"2020-05-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943129,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":27.97,"expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943128,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":20.9,"expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943127,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":17.99,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943126,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":25.24,"expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943125,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":7300,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":44.85,"expiration_date":"2025-05-12","underlying":"Common Stock","underlying_shares":7300},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943124,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":10575,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":30.33,"expiration_date":"2026-05-17","underlying":"Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943123,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":10575,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943122,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Common Stock","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":5408,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":3943121,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T16:27:44.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":43129,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000088","document":"wf-form4_152581125121121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000088/wf-form4_152581125121121.xml","form_type":"4"}},{"id":4316500,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2017-05-17T15:51:30.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":10575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vests on the earlier of (i) May 16, 2018 which is the first anniversary of the date of grant and (ii) one day before the date of the Company's next annual meeting of stockholders."}],"balance_after":10575,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001003642-17-000056","document":"wf-form4_149505067519184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000056/wf-form4_149505067519184.xml","form_type":"4"}},{"id":4316499,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":149458,"kind":"person","name":"TERRERI PETER R","position":1,"cik":"0001238456","reported_name":"TERRERI PETER R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T15:51:30.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48537,"source":{"system":"sec-edgar","filing":"0001003642-17-000056","document":"wf-form4_149505067519184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000056/wf-form4_149505067519184.xml","form_type":"4"}}]}